Role of Fatty Acid Oxidation in Crohn's Disease and Ulcerative Colitis: Metabolomics Analysis and Experimental Evidence
Cell Biochemistry and Function · 2026-07 · 44 (7)
DOI: 10.1002/cbf.70246 ↗At a glance
Journal article in Cell Biochemistry and Function, published online on 2026-07-16. Written by Fang Yan and 5 co-authors. Institution: Department of Gastroenterology, National Institution of Drug Clinical Trial, Guizhou Provincial People's Hospital, Guiyang, China. Major MEDLINE topics: Crohn Disease, Metabolomics, Colitis, Ulcerative, Fatty Acids. 14 references. The full text is freely available in PubMed Central. Funded by: Science and Technology Fund of Guizhou provincial health committee, Guizhou Provincial Science and Technology Projects.
Abstract (original language)
The metabolic determinants that distinguish Crohn's disease (CD) from ulcerative colitis (UC) and their roles in driving immune dysregulation remain elusive. We aimed to identify systemic metabolic signatures of inflammatory bowel disease (IBD) and elucidate the mechanistic link between metabolite availability and regulatory T cell (Treg) homeostasis. We performed untargeted LC‐MS‐based metabolomics on plasma from patients with CD ( n = 17), UC ( n = 13), and healthy controls ( n = 15). Pathway enrichment and topology analysis were used to identify perturbed biological processes. The functional role of identified metabolites was validated using primary murine naive CD4 + T cell differentiation assays, Seahorse XF metabolic flux analysis, and siRNA‐mediated knockdown. The therapeutic relevance was assessed in a DSS‐induced murine model of colitis. Metabolomic profiling identified 175 significant differential metabolites, revealing a profound systemic depletion of fatty acids and a specific deficit in the fatty acid oxidation (FAO) pathway in CD patients. Palmitic acid and butyrate emerged as robust diagnostic biomarkers (AUC = 0.877–0.975). In vitro, butyrate dose‐dependently promoted iTreg differentiation by increasing the oxygen consumption rate and maximal respiratory capacity. This effect was dependent on carnitine palmitoyltransferase 1A (CPT1A), as pharmacological or genetic inhibition of CPT1A ‐mediated FAO abolished butyrate's pro‐differentiation capacity. In vivo, the ability of butyrate to attenuate colitis and promote colonic iTreg accumulation was significantly reversed by the CPT1 inhibitor etomoxir. CPT1A ‐mediated fatty acid oxidation is a critical metabolic pivot through which butyrate signals to maintain immune tolerance. The systemic loss of FAO intermediates in CD patients directly contributes to impaired iTreg development, identifying the butyrate– CPT1 A axis as a potential target for precision metabolic intervention.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, National Institution of Drug Clinical Trial, Guizhou Provincial People's Hospital, Guiyang, China.
- School of Clinical Medicine, Guizhou Medical University, Guiyang, China.
Funding
- Science and Technology Fund of Guizhou provincial health committee
- Guizhou Provincial Science and Technology Projects
Cite
APA
Yan, F., Wu, S., Yuan, W., Yang, Q., Yang, J., & Cui, D. (2026). Role of Fatty Acid Oxidation in Crohn's Disease and Ulcerative Colitis: Metabolomics Analysis and Experimental Evidence. Cell Biochemistry and Function, 44(7). https://doi.org/10.1002/cbf.70246
Vancouver
Yan F, Wu S, Yuan W, Yang Q, Yang J, Cui D. Role of Fatty Acid Oxidation in Crohn's Disease and Ulcerative Colitis: Metabolomics Analysis and Experimental Evidence. Cell Biochemistry and Function. 2026;44(7). doi:10.1002/cbf.70246
BibTeX
@article{Yan2026,
author = {Yan, Fang and Wu, Shimin and Yuan, Wenqiang and Yang, Qian and Yang, Jie and Cui, Dejun},
title = {Role of Fatty Acid Oxidation in Crohn's Disease and Ulcerative Colitis: Metabolomics Analysis and Experimental Evidence},
journal = {Cell Biochemistry and Function},
year = {2026},
volume = {44},
number = {7},
doi = {10.1002/cbf.70246}
}
EUVIMED